"Targeted Therapy Cocktail" Could Control, Perhaps Cure, Cancer
Harvard medical researchers have discovered how some cancer cells develop resistance to targeted therapy treatments. The study concludes that a one-drug approach is insufficient.
What's the Latest Development?
By changing how clinicians battle cancer, Harvard medical researchers believe the disease could become manageable, if not curable. While cancer treatment has entered a relatively new stage of "targeted therapy", as opposed to chemotherapy, most treatments last just a few months before the cancer becomes resistant. Now, the Harvard researchers have pinpointed a gene which helps cancer cells develop resistance to the targeted drugs. Called the KRAS gene, it is present in approximately one in a million cancer cells, but begins to multiply rapidly once targeted therapy has killed the cancer cells without the KRAS gene.
What's the Big Idea?
The conclusion of the research is that a one-drug cancer therapy will not work, and that medicine must be developed to attack the KRAS gene and the cancer cells it inhabits. "The treatment must be tailored to the patient, and must be based on the genetic makeup of the patient’s cancer. Perhaps even more importantly, said Martin Nowak, a professor of mathematics and of biology and director of the Program for Evolutionary Dynamics, the two drugs used simultaneously must not overlap: If a single mutation allows the cancer to become resistant to both drugs, the treatment will fail just as the single-drug therapy does."
Photo credit: Shutterstock.com
Understanding thinking talents in yourself and others can build strong teams and help avoid burnout.
- Learn to collaborate within a team and identify "thinking talent" surpluses – and shortages.
- Angie McArthur teaches intelligent collaboration for Big Think Edge.
- Subscribe to Big Think Edge before we launch on March 30 to get 20% off monthly and annual memberships.
Rediscovering the principles of self-actualisation might be just the tonic that the modern world is crying out for.
Abraham Maslow was the 20th-century American psychologist best-known for explaining motivation through his hierarchy of needs, which he represented in a pyramid. At the base, our physiological needs include food, water, warmth and rest.
Using a new process, a mini-brain develops retinal cells.
- Mini-brains, or "neural organoids," are at the cutting edge of medical research.
- This is the first one that's started developing eyes.
- Stem cells are key to the growing of organoids of various body parts.
Does believing in true love make people act like jerks?
- Ghosting, or cutting off all contact suddenly with a romantic partner, is not nice.
- Growth-oriented people (who think relationships are made, not born) do not appreciate it.
- Destiny-oriented people (who believe in soulmates) are more likely to be okay with ghosting.
SMARTER FASTER trademarks owned by The Big Think, Inc. All rights reserved.